BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C - PubMed (original) (raw)
BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C
Y Kato et al. EMBO J. 1997.
Abstract
Big MAP kinase 1 (BMK1), also known as ERK5, is a mitogen-activated protein (MAP) kinase member whose biological role is largely undefined. We have shown previously that the activity of BMK1 in rat smooth muscle cells is up-regulated by oxidants. Here, we describe a constitutively active form of the MAP kinase kinase, MEK5(D), which selectively activates BMK1 but not other MAP kinases in vivo. Through utilization of MEK5(D), we have determined that a member of the MEF2 transcription factor family, MEF2C, is a protein substrate of BMK1. BMK1 dramatically enhances the transactivation activity of MEF2C by phosphorylating a serine residue at amino acid position 387 in this transcription factor. Serum is also a potent stimulator of BMK1-induced MEF2C phosphorylation, since a dominant-negative form of BMK1 specifically inhibits serum-induced activation of MEF2C. One consequence of MEF2C activation is increased transcription of the c-jun gene. Taken together, these results strongly suggest that in some cell types the MEK5/BMK1 MAP kinase signaling pathway regulates serum-induced early gene expression through the transcription factor MEF2C.
Similar articles
- MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells.
Wei X, Sun W, Fan R, Hahn J, Joetham A, Li G, Webb S, Garrington T, Dakhama A, Lucas J, Johnson GL, Gelfand EW. Wei X, et al. Eur J Immunol. 2003 Oct;33(10):2903-9. doi: 10.1002/eji.200324127. Eur J Immunol. 2003. PMID: 14515274 - Big mitogen-activated kinase regulates multiple members of the MEF2 protein family.
Kato Y, Zhao M, Morikawa A, Sugiyama T, Chakravortty D, Koide N, Yoshida T, Tapping RI, Yang Y, Yokochi T, Lee JD. Kato Y, et al. J Biol Chem. 2000 Jun 16;275(24):18534-40. doi: 10.1074/jbc.M001573200. J Biol Chem. 2000. PMID: 10849446 - Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases.
Zhao M, Liu Y, Bao M, Kato Y, Han J, Eaton JW. Zhao M, et al. Arch Biochem Biophys. 2002 Apr 15;400(2):199-207. doi: 10.1016/S0003-9861(02)00028-0. Arch Biochem Biophys. 2002. PMID: 12054430 - Role of BMK1 in regulation of growth factor-induced cellular responses.
Kato Y, Chao TH, Hayashi M, Tapping RI, Lee JD. Kato Y, et al. Immunol Res. 2000;21(2-3):233-7. doi: 10.1385/IR:21:2-3:233. Immunol Res. 2000. PMID: 10852122 Review. - Role of big mitogen-activated protein kinase 1 (BMK1) / extracellular signal-regulated kinase 5 (ERK5) in the pathogenesis and progression of atherosclerosis.
Yoshizumi M, Kyotani Y, Zhao J, Nagayama K, Ito S, Tsuji Y, Ozawa K. Yoshizumi M, et al. J Pharmacol Sci. 2012;120(4):259-63. doi: 10.1254/jphs.12r11cp. Epub 2012 Nov 20. J Pharmacol Sci. 2012. PMID: 23165802 Review.
Cited by
- ERK5 promotes autocrine expression to sustain mitogenic balance for cell fate specification in human pluripotent stem cells.
Song C, Zhang Z, Leng D, He Z, Wang X, Liu W, Zhang W, Wu Q, Zhao Q, Chen G. Song C, et al. Stem Cell Reports. 2024 Sep 10;19(9):1320-1335. doi: 10.1016/j.stemcr.2024.07.007. Epub 2024 Aug 15. Stem Cell Reports. 2024. PMID: 39151429 Free PMC article. - ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression.
Guillén-Pérez YM, Ortiz-Ruiz MJ, Márquez J, Pandiella A, Esparís-Ogando A. Guillén-Pérez YM, et al. Int J Mol Sci. 2024 Mar 14;25(6):3273. doi: 10.3390/ijms25063273. Int J Mol Sci. 2024. PMID: 38542254 Free PMC article. - MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists.
Espinosa-Gil S, Ivanova S, Alari-Pahissa E, Denizli M, Villafranca-Magdalena B, Viñas-Casas M, Bolinaga-Ayala I, Gámez-García A, Faundez-Vidiella C, Colas E, Lopez-Botet M, Zorzano A, Lizcano JM. Espinosa-Gil S, et al. Cell Death Dis. 2023 Nov 2;14(11):715. doi: 10.1038/s41419-023-06229-6. Cell Death Dis. 2023. PMID: 37919293 Free PMC article. - Mapk7 deletion in chondrocytes causes vertebral defects by reducing MEF2C/PTEN/AKT signaling.
Wu C, Liu H, Zhong D, Yang X, Liao Z, Chen Y, Zhang S, Su D, Zhang B, Li C, Tian L, Xu C, Su P. Wu C, et al. Genes Dis. 2023 Mar 24;11(2):964-977. doi: 10.1016/j.gendis.2023.02.012. eCollection 2024 Mar. Genes Dis. 2023. PMID: 37692479 Free PMC article. - The significance of ERK5 catalytic-independent functions in disease pathways.
Le NT. Le NT. Front Cell Dev Biol. 2023 Aug 4;11:1235217. doi: 10.3389/fcell.2023.1235217. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37601096 Free PMC article. Review.
References
- Oncogene. 1991 Feb;6(2):229-35 - PubMed
- Mol Cell Biol. 1997 May;17(5):2615-23 - PubMed
- Mol Cell Biol. 1991 Sep;11(9):4466-72 - PubMed
- Nature. 1992 Jul 30;358(6385):414-7 - PubMed
- Genes Dev. 1992 Sep;6(9):1783-98 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous